Publications

22 May 2012
First Look

First Look: May 22

http://mitpress.mit.edu/catalog/item/default.asp?ttype=2&tid=12819 Do you Need a New Product-Development Strategy? Authors:Alan MacCormack, W. Crandall, P. Toft, and P. Henderson Publication:Research Technology Management 55, no. 1 (January-February 2012) Abstract... View Details

Keywords: Sean Silverthorne

14 Nov 2023
Research & Ideas

The Network Effect: Why Companies Should Care About Employees’ LinkedIn Connections

the value they produce. The researchers correlated the network data to measures of success in innovation, such as investments in research and development and the number of awarded patents and their impact. The study found that companies... View Details

Keywords: by Ben Rand

Program

Families in Business

strengths of your family business and implement practices that enable high performance, shareholder loyalty, healthy family relationships, and broad social impact. Key Benefits In this family enterprise management program, you’ll learn how to establish more effective... View Details

20 Nov 2006
Research & Ideas

Open Source Science: A New Model for Innovation

scientific problem solving? Yes, and it comes from an unexpected and unrelated corner of the universe: open source software development. That's the view of Karim R. Lakhani, an assistant professor at Harvard Business School with an extensive research background in open... View Details

Keywords: by Martha Lagace

September 1991 (Revised February 1993)
Case

Burroughs Wellcome and AZT (A)

By: Willis M. Emmons III

Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details

Keywords: Governing Rules, Regulations, and Reforms; Ethics; Business and Government Relations; Communication Strategy; Health Care and Treatment; Monopoly; Intellectual Property; Research and Development; Price; Pharmaceutical Industry; London

05 Jul 2011
First Look

First Look: July 5

Extensions to our model accommodate the possibilities of multiple voucher purchases and merchant price re-optimization. Download the paper: http://www.hbs.edu/research/pdf/11-063.pdf Organizations in the Shadow of Communities... View Details

Keywords: Sean Silverthorne

March 2021 (Revised January 2023)
Case

The Trouble with TCE

By: Vincent Pons, Rafael Di Tella and Galit Goldstein

Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details

Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States

Web

Initiatives & Projects - Faculty & Research

seeks to deepen business leaders' understanding of today’s environmental challenges and to assist them in developing effective solutions. Business History The Business History Initiative seeks to facilitate learning from the past through... View Details

Web

Program Details - Doctoral

the summer may include, and not limited to: Commit to Program Dates. Program dates are not flexible; Fellows must commit to the full duration of the program; Commit to Community Standards. Fellows agree to uphold the View Details

February 2014
Article

Toward a Model of Work Redesign for Better Work and Better Life

By: Leslie A. Perlow and Erin L. Kelly

Flexible work accommodations provided by employers purport to help individuals struggling to manage work and family demands. The underlying model for change is accommodation—helping individuals accommodate their work demands with no changes in the structure of work or... View Details

Keywords: Organizational Change and Adaptation; Work-Life Balance

Find at Harvard

November 2023 (Revised April 2024)
Case

BiomX: Bringing Phage Back to the Stage

By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud

In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details

Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Biotechnology Industry; Pharmaceutical Industry